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Abstract
Background: Delirium is a heterogeneous syndrome with inattention as the core feature. There is considerable
variation in the presence and degree of other symptom domains such as altered arousal, psychotic features and
global cognitive dysfunction. Delirium is independently associated with increased mortality, but it is unclear
whether individual symptom domains of delirium have prognostic importance. We conducted a systematic review
and meta-analysis of studies in hospitalised adults in general settings to identify the relationship between symptom
domains of delirium and outcomes.
(PROSPERO: CRD42018093935).
Methods: We searched MEDLINE, EMBASE, PsycINFO, CINAHL, clinicaltrials.gov and the Cochrane Central Register of
Controlled Trials from inception to November 2019. We included studies of hospitalised adults that reported
associations between symptom domains of delirium and 30-day mortality (primary outcome), and other outcomes
including mortality at other time points, length of stay, and dementia. Reviewer pairs independently screened
articles, extracted data, and assessed risk of bias (Risk of Bias Assessment tool for Non-randomized Studies) and
quality of evidence using the Grading of Recommendations, Assessment, Development and Evaluation framework.
We performed random-effects meta-analyses stratified by delirium domain where possible.
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Results: From 7092 citations we included 6 studies (6002 patients, 1112 with delirium). Higher mortality (ranging
from in-hospital to follow-up beyond 12 months) was associated with altered arousal (pooled Odds Ratio (OR) 2.80,
95% Confidence Interval (CI) 2.33–3.37; moderate-quality evidence), inattention (pooled OR 2.57, 95% CI 1.74–3.80;
low-quality evidence), and in single studies with disorientation, memory deficits and disorganised thoughts. Risk of
bias varied across studies but was moderate-to-high overall, mainly due to selection bias, lack of blinding of
assessments and unclear risk of selective outcome reporting. We found no studies on the association between
psychotic features, visuospatial deficits or affective disturbances in delirium and outcomes, or studies reporting non-
mortality outcomes.
Conclusions: Few studies have related symptom domains of delirium to outcomes, but the available evidence
suggests that altered arousal and inattention in delirium are associated with higher mortality than normal arousal
and attention in people with or without delirium. Measurable symptom domains of delirium may have value in
predicting survival and stratifying patients for treatment. We recommend that future delirium studies report
outcomes by symptom domain.
Keywords: Delirium, Mortality, Altered mental status, Arousal, Attention, Systematic review
Background
Delirium is an acute, serious neuropsychiatric syndrome
of cognitive, psychiatric and motor abnormalities which
is commonly triggered by acute illness, surgery, trauma
or medications. Delirium affects at least 1 in 6 hospita-
lised older patients [1, 2]. It is often highly distressing
for patients and their carers [3, 4]. Most cases of delir-
ium resolve within days, though around 20% persists for
weeks or months [5].
The core feature of delirium is inattention of acute on-
set. However, the neuropsychological and neuropsychi-
atric features of delirium are wide ranging. The
syndrome of delirium may also include disturbances in
level of arousal, memory, orientation (i.e. awareness to
time, place and person), visuospatial ability, psychotic
features (i.e. misperceptions, hallucinations and illu-
sions), psychomotor activity, thought process (disorga-
nised thinking) and affect to varying degrees [6, 7].
Delirium in hospitalised adults is independently
associated with multiple adverse outcomes including a
two-fold increased risk of mortality (Hazard Ratio (HR)
1.95, 95% Confidence Interval (CI) 1.51–2.52 [8]), longer
stay in hospital, new institutionalisation (odds ratio
(OR), 2.41, 95% CI 1.77–3.29 [8]) and an 8-fold
increased risk of dementia (OR 8.7, 95% CI 2.1–35 [9])
[1, 2, 9]. Delirium severity scores, reflecting the summed
ordinal measures of various symptom domains of the de-
lirium syndrome [10–13], have also been shown to pre-
dict outcomes including mortality [14], though the
evidence is mixed [15]. However, the construct of delir-
ium severity is complex and lacks a clear operational
definition, with several domains such as altered level of
arousal, psychosis, and inattention present to varying de-
grees in tools for assessing severity. This heterogeneity
makes the study of the relationships between delirium
severity and prognosis challenging.
It is unclear whether the individual symptom domains
of the delirium syndrome are associated with adverse pa-
tient outcomes, and whether specific delirium symptoms
drive the observed association with these outcomes. In
most existing delirium severity scales, the individual
symptom domains included in the scale are equally
weighted (e.g. [11, 13].
Some studies have examined subtypes (hypo- and
hyperactive, and mixed delirium) in relation to out-
comes, mostly suggesting that hypoactive presentations
of delirium are indicative of a worse prognosis [16–18].
However these studies did not consider the individual
symptom domains. Altered arousal has been found to be
predictive of mortality - a recent systematic review in
adult hospitalised patients found an adjusted 6-fold in-
crease in risk of 30-day mortality in patients with altered
arousal [19], but none of the studies considered delir-
ium. Of interest, subsyndromal delirium, in which pa-
tients exhibit one or more symptoms but do not meet
full criteria for delirium, has been shown to carry inter-
mediate risk [20].
A better understanding of the associations between in-
dividual symptom domains of delirium and patient out-
comes is needed to inform patient risk stratification and
prioritisation of interventions for preventing and treating
delirium. In other words, identifying predictors of poor
outcomes in delirium would assist clinicians to risk
stratify patients in order to focus management and guide
discussions on prognosis. Furthermore, advancing our
understanding of the individual domains of delirium that
contribute to poor outcomes could lead to a more re-
fined operationalisation of delirium itself. This is import-
ant because the key features of delirium lack explicit and
agreed definitions, and there is continued debate about
operationalisation and assessment methods of these
features [6, 21]).
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Objectives
We conducted a systematic review to establish if the
presence of individual symptom domains of delirium in
hospitalised adults, in studies which included patients
with delirium, is associated with increased mortality and
other adverse patient outcomes. The potential effect on
outcomes of individual symptom domains of delirium
was studied in both patients with and without a delirium
diagnosis.
Methods
This systematic review was reported in accordance with
the Preferred Reporting of Items in Systematic Reviews
and Meta-Analysis (PRISMA) statement [22].
Protocol and registration
The study protocol was prospectively registered with




Study inclusion criteria were: (1) hospitalised patients
aged 18 and over; (2) patients in whom an assessment of
delirium was made using standardised diagnostic criteria
or validated tools (e.g. Confusion Assessment Method
(CAM) and its derivatives including the CAM for the In-
tensive Care Unit, Delirium Rating Scale-Revised 98
(DRS-R98), Memorial Delirium Assessment Scale, Delir-
ium Index, Delirium Observation Screening Scale, Delir-
ium Symptom Overview, or 4AT); (3) collected data on
at least one of our pre-specified outcomes (defined
below); and (4) studies which reported the outcome
stratified by presence or absence of individual symptom
domains typically considered to be part of the delirium
syndrome, including disturbance in attention, level of
arousal, memory, orientation, language, visuospatial abil-
ity, affect and thought process (disorganised thinking),
and psychotic features (including misinterpretations, hal-
lucinations and illusions).
Exclusion criteria were studies in: (1) patients with de-
lirium tremens; (2) the intensive care unit or high de-
pendency unit or a setting focused on providing
specialist end of life care (e.g. hospice); and (3) mixed
settings unless data from patients admitted to hospital
could be separated.
The primary outcome was mortality at 30 days. Sec-
ondary outcomes were mortality at other timepoints in-
cluding in-hospital mortality, as well as length of
hospital stay (days), readmission, new admission to care
home, duration of delirium, incident dementia and qual-
ity of life (after a delirium episode) as measured by a val-
idated questionnaire.
All study designs were considered.
Data sources
An inclusive search strategy was developed with an ex-
perienced librarian using selected keywords relating to
delirium, key delirium symptom domains of interest and
outcome. The search terms used to identify delirium
were based on the validated delirium search syntax
produced by the National Institute for Health and
Clinical Excellence (NICE) clinical guidance for delirium
(Additional file 1: Databases search strategies) [23]. The
following databases were searched: MEDLINE® (OVID),
EMBASE (OVID), PsycINFO (EBSCO), CINAHL
(EBSCO), clinicaltrials.gov and the Cochrane Central
Register of Controlled trials from inception to 9 May
2018, with an updated search until 21 November 2019.
No restrictions on language or publication date were
imposed. We conducted forward citation searches of in-
cluded articles and checked reference lists of included
articles for further articles of potential relevance. Where
data were not presented as outcome data stratified by
delirium domain, we contacted the authors to request ei-
ther individual patient-level data or summary data.
Professionals from the European Delirium Association,
American Delirium Society and Australasian Delirium
Association were contacted by email and social media to
identify other relevant published or unpublished articles
or data for inclusion. We also contacted relevant experts
through social media.
Study selection and data extraction
Pairs of review authors (LM and ZT; TQ and ZT) inde-
pendently reviewed all titles and abstracts for eligibility.
They then independently evaluated full texts for inclu-
sion, resolving any disagreement by discussion or, if re-
quired, by another review author (SDS). Data were
extracted independently by each reviewer and comprised
study design and setting, population (e.g. reason for ad-
mission), co-morbid illness or illness severity (e.g. de-
mentia or cognitive impairment, depression, frailty), sex,
age range, total number of patients and total number
with delirium and/or dementia, severity of delirium,
method for diagnosing delirium, time of patient assess-
ment, mortality, length of hospital stay, readmission to
hospital, new admission to care home, quality of life as-
sessment, statistic used, adjustments made to the ana-
lysis, conclusion of the study and any study quality
measures. We primarily sought hazard ratios (HR) or
odds ratios (OR) of mortality. Where there was ambigu-
ity over results, the authors were contacted for
clarification.
Risk of bias assessment and grading of quality of
evidence
The risk of bias was assessed with a modified version of
The Risk of Bias Assessment tool for Non-randomized
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Studies (RoBANS) [24], with pre-determined criteria for
low or high risk for each domain (Additional file 2:
RoBANS quality assessment criteria). The reviewer pairs
independently assessed risk of bias and agreed by
consensus.
An assessment of overall quality of evidence was made
according to the Grading of Recommendations, Assess-
ment, Development and Evaluation (GRADE) framework
[25]. We assessed risk of bias, consistency of results
(heterogeneity), directness (applicability of included
studies to research question), precision (based on CIs of
summary estimate), and publication bias. Because we
anticipated that most studies would be observational in
nature, we did not downgrade the quality of the evidence
for this factor.
Synthesis of Results
Statistical heterogeneity was assessed using a visual
assessment of forest plots supplemented with a quantita-
tive assessment (Higgins I2 [26]). Studies were synthe-
sized using meta-analyses where reporting was
sufficiently homogeneous (agreed by consensus). Quanti-
tative analysis was performed using Comprehensive
Meta-Analysis (CMA) Version 3 software [27]. To allow
summary analysis, HRs were converted to ORs using
CMA software. We calculated summary estimates where
data were reported on the same predictor variable from
three or more studies. Where mortality was reported at
multiple time points, the last point of follow-up was
used in the analysis. Since we only identified one study
on the primary outcome, 30-day mortality, we synthe-
sised the data across all mortality time points (ranging
from in-hospital mortality to follow-up beyond 12
months); this was a deviation from the pre-specified
study protocol. We conducted stratified analyses by de-
lirium symptom domain using random-effects models to
calculate pooled ORs and 95% CIs, supplemented with a
narrative analysis.
A sensitivity analysis was performed excluding one
study that included only patients with delirium [28].
Results
Study selection
We identified 7950 articles from our initial search, and
7092 after initial deduplication (Fig. 1). Following title
and abstract screening, 97 records had full-text review
and seven articles were included reporting six different
studies [28–33]. We contacted 16 authors (including
from these six studies) to request summary data, of
which 10 authors replied: 4 authors shared data, 4 au-
thors confirmed they did not report outcomes of interest
stratified by delirium symptom domains, 1 study did not
provide summary data due to a conflict of interest (i.e.
the authors plan on publishing these data at a later date)
and 1 author was unable to share data due to lack of pa-
tient consent. The main reason for exclusion of articles
was that results stratified by delirium symptom domains
were not reported and not provided by authors. Two ar-
ticles reported results from the same cohort [29, 34]: the
article which provided additional prognostic information
on a sub-domain of delirium was included in the synthe-
sis of results [29].
Study characteristics
All six studies were cohort studies, four prospective and
two retrospective. Studies were published between 2013
and 2020 from the UK, USA, Italy, and Brazil (Table 1).
Three studies were identified through conference ab-
stracts; the authors of one study provided summary data
[32] and authors of the other two studies shared the un-
published manuscript [28] or the accepted manuscript
[33]. All studies recruited hospitalised patients from
acute medical wards, orthopaedic wards or emergency
departments. The sample size varied from 108 to 2521,
with a total of 6002 patients included in the review
population of which 1112 (18.5%) had delirium as
assessed by diagnostic criteria or a validated diagnostic
instrument. Patients in one study all had a delirium
diagnosis [28]. The remaining five studies reported a
prevalence of delirium ranging from 2.9 to 44.4% (this
wide range reflecting different selection criteria). Mean
or median age ranged from 77 to 84.4 years. Baseline co-
morbidity data were collected in all studies and included
dementia diagnosis (4 studies, prevalence 38.9 to 57%),
cognitive impairment (1 study) and illness severity (3
studies).
Five studies used a delirium screening tool to assess
delirium: the CAM [35] or its variants (short CAM, or s-
CAM, and CAM for the Intensive Care Unit) and/or the
DRS-R98 [11]. Two studies reported diagnosing delirium
according to the Diagnostic Statistical Manual of Mental
Disorders, 4th Edition Text Revision (DSM-IV-TR) [28]
or the International Classification of Mental and Behav-
ioural Disorders 9th Revision Clinical Modification
(ICD-9-CM) [31] (Table 1).
Neuropsychological domains
Arousal: Five studies assessed level of arousal with vari-
ous tools: s-CAM [31, 33]; Glasgow Coma Scale [33];
Richmond Agitation-Sedation Scale (RASS; 29, 32); and/
or the Observational Scale for Level of Arousal (OSLA;
28, 32). Studies which used a scale for assessing arousal
dichotomised the scale to determine whether altered
arousal was present or absent; the degree (or severity) of
arousal disturbance was not considered. Diwell et al.
[31] did not define ‘altered level of consciousness’, but it
was clear from the paper that this term referred to al-
tered level of arousal as assessed with the short CAM
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[36]. One study distinguished between reduced and in-
creased arousal [29], another study used GCS with
scores ≤13 to indicate decreased arousal [33], and the
remaining studies did not specify whether arousal was
increased or decreased.
Attention: Attention was assessed in three studies,
using either a computerised test of focused and sus-
tained attention (Edinburgh Delirium Test Box [37])
[32], counting backwards from 20 to 1 and the Months
of the Year backwards test [30], or patient observation
(as part of the s-CAM) [31]. As with altered arousal, in-
attention was coded in the studies as present or absent,
and the degree of inattention was not considered in the
analyses.
Other neuropsychological domains: in single studies,
the presence of disorientation (name current year,
month and time of day) and memory deficits (immediate
and delayed recall), both part of the Short Blessed Test
[38], and disorganised thinking (included in the CAM as-
sessment [35]) was assessed. There were no studies that
collected data on the association between psychotic
features, visuospatial deficits or affective disturbances in
delirium with mortality, or secondary non-mortality
outcomes.
Three studies reported on the timing of the initial as-
sessment: day 1 [32] or day 3 [29, 31] after admission or
at time of enrolment [29]. No other studies reported on
timing and frequency of assessments.
Outcome measures
One study reported the primary outcome of 30-day mor-
tality [33]. Three studies reported mortality at other
follow-up timepoints, namely at 4, 6 and/or 12months
[28, 29, 32]. One study reported in-hospital mortality [30]
and another study reported mortality according to the UK
Office of National Statistics where death was flagged by a
certified death certificate, however details of the exact
timepoint of this were not provided [31] (Table 1).
We found no studies which reported on the associ-
ation between delirium symptom domains and any of
the non-mortality secondary outcomes.
Fig. 1 PRISMA flow chart of study selection [22]




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Tieges et al. BMC Geriatrics          (2021) 21:162 Page 6 of 14
All studies reported unadjusted and adjusted data.
Multivariable Cox proportional hazard models were per-
formed to produce HRs of survival in four studies [28,
29, 31, 33], and a form of logistic regression with ORs
was used in two studies [30, 32]. All studies reported
95% CIs. One study reported model adjustments for
prevalent delirium [33]. No other studies adjusted their
models for delirium or other domain impairments.
Risk of bias
Risk of bias varied across studies but was moderate to
high overall (Fig. 2). This was mainly due to: possible se-
lection bias, either because studies recruited patients
from a convenience sample and/or because of the retro-
spective study design used [29, 32, 33]; lack of reported
blinding of outcome assessments [28–30, 32, 33]; and
the absence of a pre-published protocol to allow assess-
ment of selective outcome reporting (all studies). The
risk of bias was mostly low for the consideration of con-
founding variables, with sufficient information in indi-
vidual studies regarding baseline variables such as
dementia, co-morbidities, functional dependence, frailty,
and illness severity, and inclusion of these variables in
multivariate analyses. Most studies used a validated scale
to assess delirium, although training and frequency of
assessments were often poorly reported, resulting in un-
clear risk of bias [29–31]. One study [31] diagnosed de-
lirium by retrieving ICD-9 codes from web-based case
reports without describing the method in detail (unclear
risk of bias). Four studies [28–30, 33] addressed how
missing data were treated and accounted for in the ana-
lysis (low risk of bias), whereas the remaining two stud-
ies [31, 32] did not report the number and reasons for
loss to follow-up (unclear risk of bias).
Synthesis of results
Altered level of arousal
Altered (versus normal) level of arousal (with or without
delirium) was associated with higher mortality at 30
days, and at 4, 6, and 12 months [28, 29, 32, 33] (Table 1
and Additional file 3: Table 2 expanded). Random effects
meta-analysis indicated that presence of altered arousal
(compared to normal arousal) was associated with higher
mortality across follow-up time-points ranging from 30
days to 12months (pooled OR 2.80, 95% CI 2.33–3.37,
I2 = 0%, N = 3481 (1040 delirium), risk of bias moderate-
to-high: possible selection bias, unclear or lack of blind-
ing of assessments and unclear risk of selective outcome
reporting) (Fig. 2). The quality of evidence for the asso-
ciation between altered arousal and higher mortality was
moderate, downgraded because of high risk of bias (all
but one study had unclear or high risk of bias ratings in
at least three RoBANS domains), indirectness, and publi-
cation bias.
A sensitivity analysis excluding the Jackson et al. study
[28] did not alter these findings (pooled OR 2.80; 95%
CI 2.32–3.37).
Garcez et al. [33] was the only study reporting on the
association between level of arousal and 30-day mortal-
ity, the primary outcome. In this retrospective study, al-
tered (compared to normal) arousal was independently
associated with higher 30-day mortality after adjusting
for confounders including delirium, both when
arousal was defined using s-CAM criteria (HR 2.33,
95% CI 1.66–3.27) and GCS scores (HR 1.62, 95% CI
1.13–2.33; GCS ≤ 13). The adjustment for delirium
may have led to over-adjustment especially when
using s-CAM criteria to define both arousal and delir-
ium status.
Fig. 2 Forest plot of the association between altered level of arousal and inattention with mortality, and risk of bias summary graph of all
included studies (low (−), high (+) or unclear (?))
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Hall et al. [32] reported that altered level of arousal
was associated with increased risk of death at 12 months
(OSLA: HR 2.21, 95% CI 1.01–4.86; RASS: HR 2.13, 95%
CI 1.03–4.4).
Han et al. [29] compared the associations between
each arousal subtype in delirium (normal/increased/
decreased, using non-delirious patients as the refer-
ence group) and 6-month mortality in patients pre-
senting in the emergency department. Of all three
delirium arousal subtypes, delirium with normal
arousal had the highest 6-month mortality (HR 3.1,
95% CI 1.3–7.4) although the sample size for this
subgroup was very small (N = 15). Furthermore, this
was the only paper that found an association be-
tween increased arousal in delirium and mortality
(HR 1.4, 95% CI 0.9–2.1; N = 8), again using a very
small sample size. The direction of the effect was
similar to that found for decreased arousal in delir-
ium (HR 1.4, 95% CI 0.9–2.1; N = 132). A different
paper describing the same cohort further reported
that patients with altered arousal, irrespective of de-
lirium status, were more likely to die within 6
months (HR 1.73, 95% CI 1.21–2.49) compared to
those with normal arousal [34].
Jackson et al. [28] only included patients with delirium
on admission who were followed up at 4 and 12 months.
Delirium with reduced arousal and hypoactive motor
symptoms in hospital was associated with higher mortal-
ity at 12 months when compared to delirium patients
with hyperactive features (i.e. mixed and hyperactive
motor subtypes; HR 1.09, 95% CI 1.02–1.18). In
addition, analysis of arousal subtypes, informed by scores
on the OSLA, DRS-R98 and clinical descriptions, found
an association between the hypoactive (vs. hyperactive/
mixed) subtype with higher mortality at 4 months (HR
3.18, 95% CI 1.13–8.93).
Diwell et al. [31] did not find a significant associ-
ation between level of consciousness (i.e. altered
arousal) and mortality in adjusted analysis (HR 1.33
95% CI 0.98–1.79).
Inattention
Results from the meta-analysis showed that presence of
inattention (pooled across patients with and without de-
lirium) was associated with higher mortality compared
to normal attention and/or no delirium (pooled OR
2.57, 95% CI 1.74–3.80; I2 = 0%, risk of bias moderate:
possible selection bias, unclear or lack of blinding of as-
sessments, and unclear risk of selective outcome report-
ing; 3239 patients (387 delirium)). The quality of
evidence for the association between inattention and
higher mortality was low, downgraded because of risk of
bias (all three studies had an unclear or high risk of bias
in at least three RoBANS domains), imprecision, indir-
ectness, and publication bias.
Only one of three original studies assessing attention
reported a statistically significant association between in-
attention and higher mortality. Bellelli et al. [30] re-
ported an association between inattention in older
patients (with delirium) and in-hospital mortality (OR
3.26, 95% CI 2.03–5.24) compared to a non-delirious
group. It is noted that this study reported a lower
prevalence rate of delirium (2.9%) than expected given
the setting, suggesting that a proportion of cases with
delirium were missed. Diwell et al. [31] reported a
statistically significant association between inattention
with higher mortality, but this association disappeared
after adjustment for confounders (HR 1.24, 95% CI
0.92–1.67).
Other neuropsychological deficits
The evidence regarding other symptom domains of de-
lirium and mortality is limited (two studies: 3131 pa-
tients, 343 with delirium [30, 31]). Bellelli et al. [30]
found higher in-hospital mortality in delirium patients
who had evidence of disorientation (OR 3.85, 95% CI
2.43–6.1) and memory deficits (OR 2.92, 95% CI 1.33–
6.39) compared to non-delirious patients. Interestingly,
the diagnosis of delirium itself was not a predictor of
mortality in this study. The authors further noted that
delirious patients mostly had multiple neurocognitive
deficits and that patterns of inattention with memory
and/or orientation deficits were shown to be more
strongly associated with in-hospital mortality compared
to having only one neurocognitive deficit.
Diwell et al. [31] found an association between the
presence of disorganised thinking in patients with delir-
ium (compared to no delirium) and higher mortality
(timescale not specified but identified through the UK




This systematic review demonstrates that the evidence
base regarding the association between symptom do-
mains of delirium and mortality and other outcomes is
small and has marked heterogeneity. A meta-analysis of
five studies found that altered level of arousal was asso-
ciated with 2.8-fold higher mortality, ranging from 30-
day mortality to follow-up beyond 12 months after hos-
pital admission, although the quality of evidence was low
to moderate. Meta-analysis of three studies found that
inattention associated with delirium conferred a 2.6-fold
higher risk of mortality ranging from in-hospital mortal-
ity to follow-up beyond 12months.
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The evidence on the association between other delir-
ium domains and mortality was sparse, with a lack of
data on psychotic features, visuospatial deficits and
affective disturbances.
We found no studies reporting on other outcomes
than mortality.
Strengths and limitations
This was a comprehensive systematic review evaluating
over 7000 references using an inclusive search strategy
with no initial restrictions on language, study design or
date. All references, abstracts and full texts were
reviewed by independent assessors. We contacted delir-
ium researchers around the world to identify unpub-
lished studies. We followed up conference abstracts and
performed forward citation searches. We contacted au-
thors for data and clarification. In light of predicted sig-
nificant heterogeneity, a random effects model was used
in the meta-analysis.
Several limitations must be acknowledged. Studies in-
cluded in the meta-analysis were heterogeneous, with
variation in sample size, delirium prevalence and setting.
The number of studies (N = 6) was too small to permit
additional analyses (e.g., stratified analyses by setting or
delirium subgroups). The study with the largest sample
size (N = 2521) reported a delirium prevalence of only
2.9% (N = 72), which suggests that some patients with
delirium may have been misclassified as non-delirious.
This could in turn have led to a decrease in the size of
the association seen with outcome. Although we
searched conference proceedings and contacted delirium
research organisations, we may have missed valuable
contributions in the grey literature. Also, there were no
full texts available for 12 relevant articles; these were
mainly conference abstracts and authors did not respond
to our request for the full paper or study data. We could
not identify full text articles of these records on a further
check in November 2020.
Whilst we used a comprehensive list of search terms
in an effort to capture the wide variation of descriptions
of the symptom domains of delirium and assessment
methods for measuring these symptom domains, we
cannot rule out the possibility that we may have missed
some studies.
Studies differed with regards to the comparison group
used: these were either patients without delirium, pa-
tients (either with or without delirium) who did not dis-
play the relevant symptom domain, or patients with
delirium only who did not display the symptom domain.
We did not carry out subgroup analyses because insuffi-
cient data on subgroups were provided, and it was there-
fore not possible to distinguish the impact of the
individual delirium symptom domains versus the overall
impact of a delirium diagnosis.
The included studies were of mixed quality overall,
and heterogeneous in the populations studied (with de-
lirium prevalence ranging between 2.9 to 100% due to
selection methodology, and dementia prevalence ranging
between 38.9 to 56%), methods for assessing arousal and
attention, methods of delirium assessment, adjustment
for dementia and illness severity, and the length of
follow-up of mortality. Given this clinical and methodo-
logical heterogeneity, the exploratory findings from the
meta-analysis should be interpreted with caution.
Studies mostly did not specify the timing and frequency
of delirium assessments, and it was also unclear if some
patients developed persistent delirium which could have
affected the relationship between delirium symptom do-
mains and outcomes. Nevertheless, the positive associ-
ation between altered level of arousal in delirium and
higher mortality was reasonably consistent across
studies. Studies also adjusted for key confounders
including age, comorbidity burden and dementia status.
Interpretation and implications for clinical practice and
future research
The current evidence base regarding the association be-
tween delirium symptom domains and mortality is small
and inconclusive. Nonetheless, the present findings sug-
gest that individual symptom domains of delirium may
have prognostic value. This appears to be especially true
for altered level of arousal. One study reported that al-
tered arousal in itself was a stronger indicator of mortal-
ity than a diagnosis of delirium [32], suggesting that
assessment of arousal in delirium may have prognostic
value over and above diagnostic classification. Interest-
ingly, a recent systematic review found that altered
arousal in the absence of delirium is a strong prognostic
marker of mortality [19]. In contrast to a delirium diag-
nosis which can be difficult to ascertain particularly in
the absence of a reliable informant history, level of
arousal can be quickly and objectively assessed at the
bedside with an observational tool such as the RASS
[39], OSLA [40], or by using delirium scales with em-
bedded level of arousal measurement such as the 4AT
[41]. Level of arousal is also an important component of
immediate clinical assessment e.g. using the GCS, or the
AVPU scale (A: alert; V: responds to voice; P: responds
to pain; U: unresponsive) [42], which has been integrated
into clinical ‘early warning scores’ and is therefore part
of regular observations in hospital. Further, the degree
(or severity) of disturbances in arousal and attention
might add additional prognostic information beyond a
binary score (i.e., present/absent), but this requires fur-
ther study.
More broadly, delirium assessment tools, including
tools for assessing delirium severity and monitoring for
recovery from delirium, may be challenging to
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administer in busy clinical environments, and knowledge
of the symptom domains that drive the association with
adverse outcomes could be translated into more tailored
delirium assessment tools.
Altered level of arousal, inattention and other symp-
tom domains of delirium are commonly assessed as part
of delirium assessment tools in research and clinical
practice (e.g. 3D-CAM [43], DRS-R98 [11] etc.), but in-
dividual test item or subscale scores are rarely reported.
Also, there remains considerable uncertainty with re-
spect to the conceptualisation and assessment of the
component features of delirium. We recommend more
explicit and consistent reporting of delirium symptom
domain scores and the assessment tools used (for ex-
ample Neerland et al. [44]). Such an approach of in-
creased transparency and consistency of reporting would
allow for improved assessment of study quality and fa-
cilitate further research into the prognostic utility of the
individual symptom domains of delirium.
Future research is needed to examine the prognostic
importance of delirium symptom domains not only in
relation to mortality, but also other adverse outcomes
known to be linked to delirium (including persistent
cognitive impairment and dementia, and anxiety, depres-
sive, and post-traumatic stress disorder symptoms [9,
45]). Such knowledge could inform development of in-
terventions targeted at delirium patients with deficits in
specific symptom domains, and also inform stratification
of patients for treatment and/or intervention trials. This
would require prospective cohort studies evaluating
sufficient numbers of unselected patients, and using
standardised methods for assessing the individual symp-
tom domains of delirium. Better characterisation of pres-
ence and severity of pre-existing cognitive impairment
prior to admission could be achieved using a retrospect-
ive informant questionnaire such as the Informant Ques-
tionnaire of Cognitive Decline in the Elderly (IQCODE
[46]) and/or an informant-based dementia severity rating
instrument. Further, standardisation of methods for
assessing and reporting symptom domains of the delir-
ium syndrome is also needed (both the presence and se-
verity of symptoms), because this will increase
transparency and comparability of studies and facilitate
data sharing efforts and meta-analyses of individual pa-
tient data [47]; efforts to harmonize and calibrate the
symptom domain measures are also needed to enable ef-
fective comparison and pooled analyses of study results.
With regards to outcome measures, there is a clear need
for consensus on time points for follow-up to allow
comparison between studies. Finally, this review high-
lights the need for evidence-based development and re-
finement of tools for measuring delirium severity, a
construct which is widely used yet imprecisely defined
and variably assessed [48].
Delirium is a syndrome with a wide spectrum of clin-
ical presentations. The present findings suggest that spe-
cific phenotypes of delirium (altered arousal, inattention)
in older hospitalised adults are associated with worse
outcomes and should be a focus of future research, but
the impact of impairments in other symptom domains
has not been evaluated. Exploration of the factors behind
the heterogeneity of delirium presentations and out-
comes may improve patient outcomes through risk
stratification and proactive management and inform fu-
ture research into delirium pathophysiology and
treatment.
Conclusions
This systematic review and meta-analysis showed that
few published studies have assessed the relationship
between symptom domains of delirium and mortality.
The findings suggest that specific measurable symp-
tom domains of the delirium syndrome, especially al-
tered arousal, may have value in predicting survival. If
confirmed in future studies, this would mean that pa-
tients with delirium of the altered-arousal subtype
should be identified as having a higher risk of death.
This review provides the foundation for future work
to help advance our understanding of the delirium
syndrome and to clarify risk factors and outcomes in
order to focus management and guide discussions on
prognosis, and facilitate the development of targeted
interventions for delirium.
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